BENLYSTA
NDC 49401-102, belimumab, injection, powder, lyophilized, for solution, from GlaxoSmithKline LLC.
- Product NDC
- 49401-102
- Status
- Listed
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125370
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49401-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BELIMUMAB400 mg/5mL
Pharmacologic classes
B Lymphocyte Stimulator-directed Antibody Interactions [MoA]; B Lymphocyte Stimulator-specific Inhibitor [EPC]; Decreased B Lymphocyte Activation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49401-102-01 | 49401010201 | 1 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2fa3c528-1777-4628-8a55-a69dae2381a3Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=49401-102
Use it
Look up 49401-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49401-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49401-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.